Patents by Inventor Xinxiao Sun

Xinxiao Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROBIAL PLATFORM FOR PRODUCTION OF GLYCOSYLATED COMPOUNDS
    Publication number: 20190169664
    Abstract: Host cells are metabolically engineered to consume glucose and glycerol simultaneously, and to divert glucose from catabolic to anabolic pathways without adversely affecting glucose uptake.
    Type: Application
    Filed: May 5, 2017
    Publication date: June 6, 2019
    Applicant: University of Georgia Research Foundation, Inc.
    Inventors: Yajun YAN, Yifei WU, Xinxiao SUN, Yuheng LIN
  • Precursor-directed biosynthesis of 5-hydroxytryptophan
    Patent number: 9663768
    Abstract: The invention provides compounds, compositions, non-naturally occurring organisms, and methods useful for production of 5-hydroxytryptophan (5-HTP) in a microbial cell. A microbial system which includes at least one microbial cell, such as a bacterial cell or a yeast cell, is genetically engineered to express all or a portion of non-naturally occurring biosynthetic pathway that catalyzes the conversion of a simple carbon source, such as glucose, to 5-HTP. The invention can result in improved titers of 5-HTP and permits low-cost, large scale production. Methods of making and using the genetically engineered cells are also included in the invention.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: May 30, 2017
    Assignee: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
    Inventors: Yajun Yan, Xinxiao Sun
  • PRECURSOR-DIRECTED BIOSYNTHESIS OF 5-HYDROXYTRYPTOPHAN
    Publication number: 20160060638
    Abstract: The invention provides compounds, compositions, non-naturally occurring organisms, and methods useful for production of 5-hydroxytryptophan (5-HTP) in a microbial cell. A microbial system which includes at least one microbial cell, such as a bacterial cell or a yeast cell, is genetically engineered to express all or a portion of non-naturally occurring biosynthetic pathway that catalyzes the conversion of a simple carbon source, such as glucose, to 5-HTP. The invention can result in improved titers of 5-HTP and permits low-cost, large scale production. Methods of making and using the genetically engineered cells are also included in the invention.
    Type: Application
    Filed: July 27, 2015
    Publication date: March 3, 2016
    Applicant: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
    Inventors: Yajun Yan, Xinxiao Sun